rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaol

Catalog No. :
ACVDFI809
CAS No. :
87-89-8
Molecular Formula :
C6H12O6
Molecular Weight :
180.16

IUPAC Name:(1R,2r,3S,4R,5s,6S)-cyclohexane-1,2,3,4,5,6-hexaol

rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$62.00Login to see priceIn stockInquiry
1000g98%$103.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaol
IUPAC Name(1R,2r,3S,4R,5s,6S)-cyclohexane-1,2,3,4,5,6-hexaol
MDL No.MFCD00077932
Molecular FormulaC6H12O6
Molecular Weight180.16
SMILESO[C@H]1[C@H]([C@H]([C@@H]([C@H]([C@@H]1O)O)O)O)O
InChI KeyCDAISMWEOUEBRE-GPIVLXJGSA-N
SynonymAZD 103 | D-chiro-Inositol | (1R,2R,3R,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexaol | Inosite | L-Inositol | (-)-chiro-Inositol | Mesovit | NSC-25142 | 1,2,3,4,5,6-Cyclohexanehexol | 1L-myo-Inositol | cis-1,2,3,5-trans-4,6-Cyclohexanehexol | CCRIS 6745 | Inos
CAS No.87-89-8
PubChem CID892

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVDFI809 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDNOZ836 route compound structure diagram
    ACDNOZ8369050-36-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  6. Then
  7. ACVDFI809 route product structure diagram
    ACVDFI80987-89-8 In Stock
Inquiry

2. ACVDFI809 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVDFI809 route product structure diagram
    ACVDFI80987-89-8 In Stock
Inquiry

Comments (0)